ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 18, 2025.

via HealthDay

FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine Society and published online July 14 in the Journal of Clinical Endocrinology & Metabolism. The guideline was published to coincide with ENDO 2025, the annual meeting of the Endocrine Society, held from July 12 to 15 in San Francisco.

Gail K. Adler, M.D., Ph.D., from Brigham and Women's Hospital in Boston, and colleagues developed an updated guideline for identifying and managing PA to improve diagnosis rates and encourage targeted treatment.

The authors suggest screening all individuals with hypertension for PA by measuring aldosterone and renin and determining the aldosterone-to-renin ratio, with the results guiding subsequent clinical care. Individuals with PA should receive medical or surgical PA-specific therapy. In individuals who screen positive for PA, commencement of PA-specific medical therapy is suggested in those who do not desire or are not candidates for surgery and in situations where the probability of lateralizing PA is low based on screening results. Aldosterone suppression testing is suggested in situations in which screening results indicate an intermediate probability for lateralizing PA and patients wish to pursue eligibility for surgical therapy. Adrenal lateralization with computed tomography scanning and adrenal venous sampling is suggested prior to deciding the treatment approach in those who test positive by aldosterone suppression testing and in those in whom screening results show a high probability of lateralizing PA. In the medical treatment of PA, mineralocorticoid receptor antagonists are suggested over epithelial sodium-channel inhibitors.

"With a low-cost blood test, we could identify more people who have primary aldosteronism and ensure they receive the proper treatment for the condition," Adler said in a statement.

Several authors disclosed ties to the pharmaceutical and biotechnology industries.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-19 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords